Dashboard
Manage Tickers

XYLXylem Inc.

NYSE xylem.com


$ 132.54 $ 1.79 (1.37 %)    

Friday, 26-Apr-2024 15:59:49 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 132.4
$ 130.69
$ 0.00 x 0
$ 0.00 x 0
$ 130.13 - $ 132.60
$ 87.05 - $ 132.65
1,112,276
na
28.89B
$ 1.13
$ 47.43
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-28-2024 12-31-2023 10-K
2 10-31-2023 09-30-2023 10-Q
3 08-04-2023 06-30-2023 10-Q
4 05-04-2023 03-31-2023 10-Q
5 02-24-2023 12-31-2022 10-K
6 11-01-2022 09-30-2022 10-Q
7 08-02-2022 06-30-2022 10-Q
8 05-04-2022 03-31-2022 10-Q
9 02-25-2022 12-31-2021 10-K
10 11-02-2021 09-30-2021 10-Q
11 08-03-2021 06-30-2021 10-Q
12 05-04-2021 03-31-2021 10-Q
13 02-26-2021 12-31-2020 10-K
14 10-29-2020 09-30-2020 10-Q
15 07-30-2020 06-30-2020 10-Q
16 05-05-2020 03-31-2020 10-Q
17 02-28-2020 12-31-2019 10-K
18 10-31-2019 09-30-2019 10-Q
19 08-01-2019 06-30-2019 10-Q
20 05-02-2019 03-31-2019 10-Q
21 02-22-2019 12-31-2018 10-K
22 10-30-2018 09-30-2018 10-Q
23 07-31-2018 06-30-2018 10-Q
24 05-01-2018 03-31-2018 10-Q
25 02-23-2018 12-31-2017 10-K
26 10-31-2017 09-30-2017 10-Q
27 08-01-2017 06-30-2017 10-Q
28 05-02-2017 03-31-2017 10-Q
29 02-23-2017 12-31-2016 10-K
30 11-01-2016 09-30-2016 10-Q
31 08-02-2016 06-30-2016 10-Q
32 05-03-2016 03-31-2016 10-Q
33 02-26-2016 12-31-2015 10-K
34 10-29-2015 09-30-2015 10-Q
35 07-30-2015 06-30-2015 10-Q
36 04-30-2015 03-31-2015 10-Q
37 02-26-2015 12-31-2014 10-K
38 10-28-2014 09-30-2014 10-Q
39 07-29-2014 06-30-2014 10-Q
40 04-29-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

the-analyst-verdict-xylem-in-the-eyes-of-7-experts
The Analyst Verdict: Xylem In The Eyes Of ...
04/18/2024 15:01:50

oppenheimer-maintains-outperform-on-xylem-raises-price-target-to-142
Oppenheimer Maintains Outperform on Xylem,...
04/18/2024 13:05:16

Oppenheimer analyst Bryan Blair maintains Xylem (NYSE:XYL) with a Outperform and raises the price target from $133 to $142.

citigroup-maintains-neutral-on-xylem-raises-price-target-to-139
Citigroup Maintains Neutral on Xylem, Rais...
04/08/2024 23:14:03

Citigroup analyst Andrew Kaplowitz maintains Xylem (NYSE:XYL) with a Neutral and raises the price target from $126 to $139.

peering-into-xylems-recent-short-interest
Peering Into Xylem's Recent Short Interest
03/22/2024 13:45:19

baird-maintains-outperform-on-xylem-raises-price-target-to-148
Baird Maintains Outperform on Xylem, Raise...
03/21/2024 17:59:38

Baird analyst Michael Halloran maintains Xylem (NYSE:XYL) with a Outperform and raises the price target from $141 to $148.

the-analyst-landscape-6-takes-on-xylem
The Analyst Landscape: 6 Takes On Xylem
03/12/2024 17:01:01

exane-bnp-paribas-initiates-coverage-on-xylem-with-outperform-rating-announces-price-target-of-150
Exane BNP Paribas Initiates Coverage On Xy...
03/12/2024 16:16:14

Exane BNP Paribas analyst Andrew Buscaglia initiates coverage on Xylem (NYSE:XYL) with a Outperform rating and announces Pri...

xylem-dexcom-and-2-other-stocks-insiders-are-selling
Xylem, DexCom And 2 Other Stocks Insiders ...
02/22/2024 12:55:49

The Nasdaq 100 closed lower by around 0.4% on Wednesday. Investors, meanwhile, focused on some notable insider trades.

xylem-collaborates-with-partners-and-communities-globally-to-accelerate-progress-on-water-security-in-2023
Xylem Collaborates With Partners And Commu...
02/22/2024 10:01:49

xylems-ex-dividend-date-is-tuesday-heres-what-you-need-to-know
Xylem's Ex-Dividend Date Is Tuesday, Here'...
02/15/2024 14:45:44

citigroup-maintains-neutral-on-xylem-raises-price-target-to-126
Citigroup Maintains Neutral on Xylem, Rais...
02/07/2024 19:50:27

Citigroup analyst Andrew Kaplowitz maintains Xylem (NYSE:XYL) with a Neutral and raises the price target from $122 to $126.

forecasting-the-future-6-analyst-projections-for-xylem
Forecasting The Future: 6 Analyst Projecti...
02/07/2024 18:00:26

rbc-capital-maintains-outperform-on-xylem-raises-price-target-to-145
RBC Capital Maintains Outperform on Xylem,...
02/07/2024 17:46:07

RBC Capital analyst Deane Dray maintains Xylem (NYSE:XYL) with a Outperform and raises the price target from $140 to $145.

why-water-technology-company-xylem-shares-are-seeing-blue-skies-today
Why Water Technology Company Xylem Shares ...
02/06/2024 16:47:37

Xylem shines in Q4 FY23, boasting 41% revenue growth to $2.12 billion, surpassing market expectations. Orders and backlog surge...

xylem-expects-fy24-adj-eps-of-400-420-vs-407-est-sales-guidance-of-84b-85b-vs-842b-est
Xylem Expects FY24 Adj EPS of $4.00-$4.20 ...
02/06/2024 12:01:26

xylem-q4-adj-eps-099-beats-096-estimate-sales-212b-beat-205b-estimate
Xylem Q4 Adj. EPS $0.99 Beats $0.96 Estima...
02/06/2024 11:57:22

Xylem (NYSE:XYL) reported quarterly earnings of $0.99 per share which beat the analyst consensus estimate of $0.96 by 3.13 perc...

earnings-scheduled-for-february-6-2024
Earnings Scheduled For February 6, 2024
02/06/2024 10:42:06

Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of ...

xylem-inks-three-year-publiacqua-contract-to-support-italys-sustainable-water-future-no-terms-disclosed
Xylem Inks Three-Year Publiacqua Contract ...
01/18/2024 10:02:29

how-is-the-market-feeling-about-xylem
How Is The Market Feeling About Xylem?
01/12/2024 19:45:12

100-invested-in-this-stock-10-years-ago-would-be-worth-300-today
$100 Invested In This Stock 10 Years Ago W...
01/05/2024 18:30:17

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION